Research on Complex Generics
Program description
The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.
Eligibility
Only the following applicant is eligible to apply for this single source funding: The University of Maryland
Past awards
Federal awards made under Assistance Listing 93.103 in FY2022–FY2026, from USAspending.gov.
- Awards made
- 584
- FY2022–FY2026
- Total awarded
- $537.9M
- FY2022–FY2026
- Typical award
- $193K
- Middle half $66.6K–$649.5K
- States & territories
- 52
- with at least one award
Typical award is the median of FY2026 awards; half of awards fell between the quartiles shown.
| Year | Total awarded | Awards |
|---|---|---|
| FY2022 | $109.8M | 115 |
| FY2023 | $162.4M | 172 |
| FY2024 | $123.4M | 95 |
| FY2025 | $108.3M | 128 |
| FY2026 | $33.9M | 74 |
Where awards went
Top states by dollars, all years on record
- California$157.4M · 64 awards
- Arizona$156.6M · 21 awards
- Maryland$141.7M · 38 awards
- Pennsylvania$137.7M · 61 awards
- Virginia$125.2M · 32 awards
Who wins
Share of awards by recipient type
- Unclassified by USAspending72% · 703 awards
- Nonprofits10% · 97 awards
- Colleges & universities10% · 95 awards
- Small businesses4% · 40 awards
- State & local governments4% · 36 awards
- For-profit companies<1% · 7 awards
Source: USAspending.gov award records for this assistance listing, which can fund more than one opportunity. This is history, not a guarantee: future award sizes, counts and eligible recipients may differ. Exact total for FY2022–FY2026: $537,912,677.
Contact
Patrick Johnson Grants Management Specialist Food and Drug Administration
patrick.johnson@fda.hhs.gov